Retractable Technologies, Inc. (NYSE:RVP)

Tuesday, November 16, 2021 | Web News
Retractable Technologies, Inc. (NYSE:RVP) ($12.25; $417.2M market cap) (medical device;safety syringes) filed its Q3 2021...
Tuesday, August 17, 2021 | Web News
Retractable Technologies, Inc. (NYSE:RVP) ($12.25; $417.2M market cap) (medical device;safety syringes) filed its Q2 2021...
Wednesday, June 2, 2021 | Web News
Retractable Technologies, Inc. (NYSE:RVP) ($10.06; $342.0M market cap) (medical device;safety syringes) announced (yesterday during...
See All Research...
Tuesday, March 10, 2020, 3:16 PM
Retractable Technologies Inc: A Better Mousetrap That Needs Market Traction
See All Articles and Reports...
Sunday, February 25, 2024, 12:00 PM
Unpacking A Wide Array Of Investment Ideas Discussed At First 2024 Skull Session Roundtable [GeoWire Weekly No. 124]
See All GeoWire Weekly...
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Web site: http://www.retractable.com

Last updated June 14, 2021


Market Data powered by QuoteMedia. Terms of Use